<DOC>
	<DOCNO>NCT00309478</DOCNO>
	<brief_summary>Primarily , clinical investigation compare efficacy cyclophosphamide + methotrexate + fluorouracil chemotherapy vs. goserelin + tamoxifen treatment term prognosis ( disease-free survival , overall survival ) premenopausal patient potentially curative , operate hormone receptor-positive breast cancer .</brief_summary>
	<brief_title>Randomized Study Comparing CMF Goserelin + Tamoxifen Premenopausal Receptor-Positive Patients</brief_title>
	<detailed_description />
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Goserelin</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>Premenopausal patient histologically verify , lymph nodenegative ( pT1cpT3 ) lymph nodepositive ( pT1apT3 ) breast cancer Hormone receptorpositive status More 6 histologically examine lymph node Laboratory parameter 1. hematopoiesis : &gt; 3500/l leukocyte , &gt; 100,000/l thrombocyte 2. renal function : creatinin &lt; 1.5mg % 3. hepatic function : GOT &lt; /= 2.5 x UNL 4. bilirubin : &lt; 1.5mg % 5. metabolic parameter : Na , Ca , K normal range , normal level blood sugar 6. blood coagulation : PZ &gt; 60 % Concluded healing process follow surgery &lt; /= 4 week interval since surgery Informed consent T4 carcinoma ; inflammatory breast cancer , carcinoma situ Simultaneous sequential bilateral breast cancer Preoperative tumorreducing radiotherapy preoperative tumorspecific medical treatment Male patient Pregnancy lactation Lacking compliance understanding disease General contraindication cytostatic treatment Serious concomitant disease prevent implementation adjuvant therapy regular followup Second carcinoma status post second carcinoma ( except curatively treat squamous cell carcinoma skin cervical carcinoma situ )</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 1999</verification_date>
	<keyword>Cyclophosphamide</keyword>
	<keyword>Methotrexate</keyword>
	<keyword>Fluorouracil</keyword>
	<keyword>Goserelin</keyword>
	<keyword>Tamoxifen</keyword>
	<keyword>Breast cancer</keyword>
</DOC>